
In high school, I had an incredibly enthusiastic biology teacher who covered his classroom walls with magnetic boards and created magnets representing the molecules, biological systems, and organs we were learning about. One day, he taught us how substances like caffeine, nicotine, and cocaine affect the brain at a molecular level, and I immediately became fascinated by how the brain responds to these compounds.
Later, when I joined the Murray Addiction Interoception Motivation (AIM) Lab at the University of Guelph, I discovered the many ways researchers can investigate different aspects of substance use disorders and the complex factors that contribute to them. The Murray AIM Lab is a behavioural neuroscience laboratory based in the Department of Psychology at the University of Guelph that investigates the behaviour-altering effects of drugs of abuse. This pursuit of knowledge continues to motivate me, but so does the opportunity to conduct research that has the potential to improve human health. With the opioid epidemic remaining a significant public health concern, I feel strongly motivated to continue studying opioids and opioid use disorder in the hopes of contributing to solutions that can make a meaningful difference.
Looking Inward: The Findings on Internal Effects
My research broadly focuses on understanding the factors that contribute to opioid use disorders and on investigating safer alternatives to opioid medications. During my MSc at the University of Guelph, I investigated a simple but important question: do different opioids feel different internally? This question is highly relevant to addiction research because, although some opioids appear to be more addictive than others, there is still little agreement about whether this difference is due to people experiencing them as producing distinct internal effects, or if there are other factors at play that are driving this difference in addictive potential.
To explore this question, I trained rats to recognize and distinguish between the internal effects, known as the interoceptive effects, of a dose of morphine and a dose of saline. Once they learned this difference, I gave them other opioids—including oxycodone, fentanyl, and hydromorphone—and observed whether they responded as though they had received morphine or saline. This allowed me to determine whether the rats experienced these drugs as producing internal effects that were similar to or different from those of morphine. Interestingly, the rats treated all of these opioids as being similar to morphine, suggesting that these drugs produce broadly comparable internal effects at a baseline pharmacological level. This finding indicates that differences in the addictive potential of various opioids seen in humans are likely driven by factors beyond these initial internal drug effects alone.
Pain Relief Research on Modern Medication

Now, in my PhD, I plan to investigate the addictive potential of a few new pain medications that may one day help to reduce our reliance on opioids. To do this, I will study how these drugs influence responses to rewarding experiences. Specifically, I will train rats to work for sucrose, a highly rewarding substance for them, and then examine whether treatment with these novel pain medications causes them to consume more, less, or the same amount of sucrose. These findings will help us better understand whether these new drugs carry a risk of promoting addictive behaviours while still providing pain relief.
Once I determine how these new pain medications influence sucrose consumption behaviour in healthy rats, I plan to repeat this research in a group of rats that serve as a model of chronic pain. It is important to me that my research uses models that closely reflect the populations who may ultimately benefit from these treatments. Since pain is one of the primary reasons people use opioids, understanding how these new medications work in the context of chronic pain will be a critical step toward determining their potential as safer alternatives to opioids.
I expect this project to span the entirety of my PhD. If additional time allows, I would also like to investigate whether the results of my planned studies change when rats are trained to work for an opioid instead of sucrose. Because these new pain medications may eventually be used alongside opioids, it is important to understand whether they influence opioid-related reward and addictive potential. This additional research would help provide a more complete picture of how these medications may be used safely in the future.
Following the completion of my PhD, I hope to pursue a career in scientific communication. I am passionate about translating complex research findings into accessible and engaging content that allows the public to better understand and benefit from scientific discoveries.
The University of Guelph has been an integral part of my academic journey—I love it here! My PhD is my third degree at the University of Guelph, and I am incredibly grateful for the people, community, campus, and opportunities that have shaped my experience. I am proud to be both a U of G student and alumna!